NCT03568474

Brief Summary

This study is comparing between the Silver Diamine Fluoride after minimal caries removal versus glass ionomer in permanent teeth with open apex

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Oct 2018

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 4, 2018

Completed
22 days until next milestone

First Posted

Study publicly available on registry

June 26, 2018

Completed
3 months until next milestone

Study Start

First participant enrolled

October 1, 2018

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2019

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2020

Completed
Last Updated

June 26, 2018

Status Verified

June 1, 2018

Enrollment Period

1 year

First QC Date

June 4, 2018

Last Update Submit

June 23, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Postoperative Pain

    Will be assessed by questioning the patient or the guardian whether there is postoperative pain or not, Binary (yes or no)

    9 months

Secondary Outcomes (4)

  • Tooth vitality

    9 months

  • Abscess

    9 months

  • Pain on percussion

    9 months

  • Root lengthening

    9 months

Study Arms (2)

Silver Diamine Fluoride

EXPERIMENTAL

Silver Diamine fluoride will be applied after after minimal caries removal then glass ionomer over it followed by composite resin restoration.

Drug: Silver Diamine FluorideDrug: Glass Ionomer

Glass Ionomer

ACTIVE COMPARATOR

Glass ionomer will be applied after minimal caries removal followed by composite resin restoration.

Drug: Glass Ionomer

Interventions

Indirect pulp capping material

Also known as: SDF
Silver Diamine Fluoride

Indirect pulp capping material

Also known as: GI
Glass IonomerSilver Diamine Fluoride

Eligibility Criteria

Age6 Years - 9 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Patients free from any systematic diseases.
  • Young permanent molars with incompletely formed roots having deep carious lesions according to clinical and radiographic examination and at risk of pulp exposure if complete caries is removed.
  • Absence of clinical pathologic signs (fistula, swelling and abnormal tooth mobility)
  • The absence of clinical symptoms of irreversible pulpitis.
  • Absence of adverse radiographic findings (interradicular or periapical radiolucencies, thickening of the periodontal space, internal and external root resorption).
  • Compliant patient/ parent.

You may not qualify if:

  • Teeth with previous restorative treatment.
  • Unrestorable teeth.
  • Uncooperative patients.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

silver diamine fluorideglass ionomer

Study Officials

  • Nevine G Waly, Professor

    Pediatric Dentistry, Faculty of Dentistry, Cairo University

    STUDY CHAIR
  • Sara A Mahmoud, PhD

    Pediatric Dentistry, Faculty of Dentistry, Cairo University

    STUDY DIRECTOR
  • Mohamed K Zayt, PhD

    Oral and Maxillofacial Radiology, Faculty of Dentistry, Cairo University

    STUDY DIRECTOR
  • Rehan A Ibrahim, MSc

    Pediatric Dentistry, Faculty of Dentistry, Cairo University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sara A Mahmoud, PhD

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
The participant, care provider, outcomes assessor and statistician will be masked
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: parallel two arm groups with 1:1 allocation ratio
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

June 4, 2018

First Posted

June 26, 2018

Study Start

October 1, 2018

Primary Completion

October 1, 2019

Study Completion

April 1, 2020

Last Updated

June 26, 2018

Record last verified: 2018-06

Data Sharing

IPD Sharing
Will share

thesis and article publication

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
after cessation of the study
Access Criteria
Internet